"Advances in human genetic technology and the arrival of the era of big data have brought cancer into a new era of precision medicine ." On April 8, at the 8th CSCO Shanghai International Lung Cancer Forum in Shanghai, an internationally renowned oncologist, Director of the National Lung Cancer Research Program, Ronald B., Sida Sainai Medical Center, USA Dr. Natale said that precision medicine has become a new trend in the treatment of cancer. “Lung cancer has a clear driving gene and is more suitable for precision therapy. It uses genetic sequencing to find targets for genetic mutations in cancer patients, supplemented with targeted chemotherapy drugs for 'precise blows', and then accurately tracked through therapeutic monitoring markers. The therapeutic effect, in order to adjust the treatment plan at any time, is the whole process of precise medical treatment of lung cancer. Therefore, lung cancer is expected to become a controllable and manageable chronic disease, and the survival time and quality of life of patients will also be greatly improved."
As the world's number one cancer killer, the incidence of lung cancer has continued to rise in the world in recent years, and this trend is particularly evident in China.
Ronald B. Founded in 1902, Dr. Natale's Sida Saina Cancer Center is an international leader in heart disease, neurological diseases and cancer treatment. In recent years, breakthroughs have been made in the early diagnosis and gene therapy of lung cancer. In addition to EGFR and ALK tests, there are ROS1, BRAF and HER2. The center currently uses two next-generation gene sequencers. The new diagnostic method can perform in-depth sequencing of 50 cancer genes and identify 2800 cancer-related gene mutations to help patients achieve higher efficiency and longer survival time.
At the Sida Sainai Medical Center, cancer patients start from admission, and individualized doctors give individualized treatment options instead of waiting until the patient's advanced or difficult condition occurs.
"Because there is a clear driving gene, lung cancer is a very advantageous cancer in the precision medical field. We use genetic sequencing to find targets for genetic mutations in cancer patients, and then use targeted chemotherapy drugs to 'precisely strike' And then accurately track the treatment through the efficacy monitoring markers to adjust the treatment at any time,†Dr. Natale said.
Blowing Mouth,Disposable Blowing Mouth,Filter Spirometer Mouthpiece,Disposable Spirometer Mouthpiece
Hengshui Qifei Paper Products Co. LTD , https://www.hengshuiqifei.com